Evofem Biosciences (EVFM) Return on Sales [ROS] (2020 - 2026)
Evofem Biosciences (EVFM) reported Return on Sales [ROS] of -94.53% for Q2 2026, down 68.60 percentage points from -25.93% a year earlier but up 413.70 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' Return on Sales [ROS] came in at -15.31%, up 9.98 percentage points year-over-year; for FY2025, it was 16.71%, up 56.35 percentage points from FY2024.
- Return on Sales [ROS] has increased for five consecutive years, with a five-year change of +23250.79 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -39.64% in FY2024 (+58.32 pp), -97.96% in FY2023 (+401.67 pp), -499.64% in FY2022 (+1523.66 pp) and -2023.30% in FY2021 (+21210.78 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -6658.56% in Q4 2022 and a high of 38.70% in Q1 2025.
- Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of -37.11 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2021 (a gain of 20291.76 percentage points); the low point was Q4 2022 (a drop of 5610.44 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -508.23% (Q1 2026), 34.99% (Q4 2025) and 19.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 28.37% |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | -94.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94.53% |
| Mar 31, 2026 | -508.23% |
| Dec 31, 2025 | 34.99% |
| Sep 30, 2025 | 19.20% |
| Jun 30, 2025 | -25.93% |
| Mar 31, 2025 | 38.70% |
| Dec 31, 2024 | -14.12% |
| Sep 30, 2024 | -54.27% |
| Jun 30, 2024 | -33.39% |
| Mar 31, 2024 | -78.93% |
| Dec 31, 2023 | -69.85% |
| Sep 30, 2023 | -69.48% |
| Jun 30, 2023 | -298.45% |
| Mar 31, 2023 | -61.61% |
| Dec 31, 2022 | -6,658.56% |
| Sep 30, 2022 | -293.89% |
| Jun 30, 2022 | -404.69% |
| Mar 31, 2022 | -680.52% |
| Dec 31, 2021 | -1,048.12% |
| Sep 30, 2021 | -2,533.24% |
API Access
Evofem Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();